377 related articles for article (PubMed ID: 30458856)
21. Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer.
Bhardwaj A; Embury MD; Ju Z; Wang J; Bedrosian I
BMC Cancer; 2022 Mar; 22(1):282. PubMed ID: 35296281
[TBL] [Abstract][Full Text] [Related]
22. The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.
Fang WT; Li HJ; Zhang H; Jiang S
Br J Clin Pharmacol; 2012 Nov; 74(5):744-56. PubMed ID: 22376147
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users.
Kumar AS; Benz CC; Shim V; Minami CA; Moore DH; Esserman LJ
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1028-33. PubMed ID: 18463402
[TBL] [Abstract][Full Text] [Related]
24. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
[TBL] [Abstract][Full Text] [Related]
25. Statin use and breast cancer: do we need more evidence and what should this be?
Bonovas S; Lytras T; Sitaras NM
Expert Opin Drug Saf; 2014 Mar; 13(3):271-5. PubMed ID: 24517162
[TBL] [Abstract][Full Text] [Related]
26. Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety.
Kulik A; Ruel M
Expert Opin Drug Saf; 2009 Sep; 8(5):559-71. PubMed ID: 19673591
[TBL] [Abstract][Full Text] [Related]
27. Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia.
Chang WT; Lin HW; Lin SH; Li YH
JAMA Netw Open; 2023 Apr; 6(4):e239515. PubMed ID: 37083661
[TBL] [Abstract][Full Text] [Related]
28. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
29. Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database.
Kim DS; Ahn HS; Kim HJ
Int J Cancer; 2022 Apr; 150(7):1156-1165. PubMed ID: 34751444
[TBL] [Abstract][Full Text] [Related]
30. Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors.
Harputluoglu H; Dizdar O; Karaahmet F; Altundag K
Breast Cancer Res Treat; 2008 Aug; 110(3):541. PubMed ID: 17851754
[No Abstract] [Full Text] [Related]
31. Long-term efficacy and safety of statin treatment beyond six years: a meta-analysis of randomized controlled trials with extended follow-up.
Lv HL; Jin DM; Liu M; Liu YM; Wang JF; Geng DF
Pharmacol Res; 2014 Mar; 81():64-73. PubMed ID: 24602799
[TBL] [Abstract][Full Text] [Related]
32. Statins and breast cancer: a smoking gun or guilt by association?
Ahmed MH; Osman MM; Alokail MS
Expert Opin Drug Saf; 2006 Sep; 5(5):599-601. PubMed ID: 16907648
[TBL] [Abstract][Full Text] [Related]
33. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
[TBL] [Abstract][Full Text] [Related]
34. Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer Study.
Inasu M; Feldt M; Jernström H; Borgquist S; Harborg S
Breast; 2022 Feb; 61():123-128. PubMed ID: 34995921
[TBL] [Abstract][Full Text] [Related]
35. Withdrawal of statins increases event rates in patients with acute coronary syndromes.
Heeschen C; Hamm CW; Laufs U; Snapinn S; Böhm M; White HD;
Circulation; 2002 Mar; 105(12):1446-52. PubMed ID: 11914253
[TBL] [Abstract][Full Text] [Related]
36. Statin Use in Older Adults with Stable Atherosclerotic Cardiovascular Disease.
Spencer-Bonilla G; Chung S; Sarraju A; Heidenreich P; Palaniappan L; Rodriguez F
J Am Geriatr Soc; 2021 Apr; 69(4):979-985. PubMed ID: 33410499
[TBL] [Abstract][Full Text] [Related]
37. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
38. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
Athyros VG; Boutari C; Stavropoulos K; Anagnostis P; Imprialos KP; Doumas M; Karagiannis A
Curr Vasc Pharmacol; 2018; 16(3):246-253. PubMed ID: 28676019
[TBL] [Abstract][Full Text] [Related]
39. Statins and prostate cancer prevention: where we are now, and future directions.
Murtola TJ; Visakorpi T; Lahtela J; Syvälä H; Tammela TLj
Nat Clin Pract Urol; 2008 Jul; 5(7):376-87. PubMed ID: 18542103
[TBL] [Abstract][Full Text] [Related]
40. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
Vrecer M; Turk S; Drinovec J; Mrhar A
Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
